These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 3475819)

  • 1. Alloimmunization following platelet transfusions in patients with acute nonlymphocytic leukemia.
    Nozaki H; Shimizu M; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Aug; 11(3):201-4. PubMed ID: 3475819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized.
    Dutcher JP; Schiffer CA; Aisner J; Wiernik PH
    Blood; 1981 Nov; 58(5):1007-11. PubMed ID: 6794674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
    Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
    Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet antibody screening in patients with leukemia and aplastic anemia.
    Chow MP; Yung CH; Tzeng JL; Hu HY; Lin WM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):237-41. PubMed ID: 1646672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
    Santoso S; Kiefel V; Kühn J; Mueller-Eckhardt G; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():153-6. PubMed ID: 1703818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of anti-HLA antibody by lymphocytotoxicity test in patients with hematopoietic diseases].
    Kambayashi H; Ohto H; Kariyone S; Tanaka T
    Rinsho Ketsueki; 1989 Jun; 30(6):815-22. PubMed ID: 2795892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. The use of platelet transfusions.
    Feusner J
    Am J Pediatr Hematol Oncol; 1984; 6(3):255-60. PubMed ID: 6393789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ineffective platelet transfusion in patients with hematology malignancy].
    Chen S; Xiao L; Zou X
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):824-6. PubMed ID: 11038776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases.
    Klingemann HG; Self S; Banaji M; Deeg HJ; Doney K; Slichter SJ; Thomas ED; Storb R
    Br J Haematol; 1987 May; 66(1):115-21. PubMed ID: 3593647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products.
    Slichter SJ; Bolgiano D; Kao KJ; Kickler TS; McFarland J; McCullough J; Woodson R
    Transfus Med Rev; 2011 Apr; 25(2):102-10. PubMed ID: 21345638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
    Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of anti-platelet antibodies using flow cytometry].
    Tsubaki K
    Rinsho Byori; 1993 Sep; 41(9):998-1006. PubMed ID: 8254978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloimmunization following platelet transfusion: the absence of a dose-response relationship.
    Dutcher JP; Schiffer CA; Aisner J; Wiernik PH
    Blood; 1981 Mar; 57(3):395-8. PubMed ID: 7459428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloimmunization following prophylactic granulocyte transfusion.
    Schiffer CA; Aisner J; Daly PA; Schimpff SC; Wiernik PH
    Blood; 1979 Oct; 54(4):766-74. PubMed ID: 476300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryopreserved autologous platelet transfusions in alloimmunized patients with acute leukemia.
    Wiesneth M; Koerner K; Funke I; Seifried E; Cardoso M; Heimpel H; Kubanek B
    Beitr Infusionsther; 1992; 30():297-300. PubMed ID: 1284720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.